Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Axonics Market Growth Strengthens Boston Scientific S Future is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Axonics' Market Growth Strengthens Boston Scientific's Future
Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative treatments. Click for more on AXNX stock. Read More
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth
A key element of Boston Scientific's growth strategy has been its acquisition of Axonics, which closed on November 15, 2024. This acquisition is expected to be accretive to revenue growth rates ... Read More
Boston Scientific: Portfolio Updates Driving Top-Line Growth
Boston Scientific has struck a better growth pattern in the past ten years, coinciding with more active acquisition activities during this period. Read more about BSX here. Read More
Boston Scientific Closes Acquisition of Axonics, Inc.
The addition of the Axonics product portfolio enables us to expand into sacral neuromodulation, a high-growth adjacency for our Urology business, while bringing a comprehensive portfolio of ... Read More
Boston Scientific completes Axonics acquisition - Investing.com
This transaction is a part of Boston Scientific's ongoing strategy to enhance its product offerings and strengthen its position in the medical technology market. Read More
Boston Scientific’s Strong Growth Trajectory Justifies Buy Rating ...
Moreover, Boston Scientific’s management has a positive outlook for the future, with expectations of above-market sales growth and double-digit EPS growth into 2025, supported by new product ... Read More
Axonic’s stock soars after cash buyout deal with Boston Scientific ...
Under terms of deal, Boston Scientific will pay $71 for each Axonics shares outstanding, which represents a 23.3% premium to Friday’s closing price of $57.57. Read More
Boston Scientific closes acquisition of Axonics - Nasdaq
Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an equity value of $3.7B and an enterprise value of $3.3B. Read More
Boston Scientific completes Axonics acquisition By Investing.com
Axonics' strong financial position is evident from InvestingPro Tips, which highlight that the company "holds more cash than debt on its balance sheet" and "liquid assets exceed short term obligations ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus